TY - JOUR
T1 - Implementing a Preeclampsia Prediction Model in Obstetrics
T2 - Cutoff Determination and Health Care Professionals' Adherence
AU - van Montfort, Pim
AU - Smits, Luc J. M.
AU - van Dooren, Ivo M. A.
AU - Lemmens, Stephanie M. P.
AU - Zelis, Maartje
AU - Zwaan, Iris M.
AU - Spaanderman, Marc E. A.
AU - Scheepers, Hubertina C. J.
N1 - Funding Information:
https://orcid.org/0000-0001-7292-9810 van Montfort Pim Department of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Limburg, the Netherlands Smits Luc J. M. Department of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Limburg, the Netherlands van Dooren Ivo M. A. Department of Obstetrics and Gynecology, Sint Jans Gasthuis Weert, Weert, Limburg, the Netherlands https://orcid.org/0000-0002-0312-897X Lemmens Stephanie M. P. Department of Obstetrics and Gynecology, School for Oncology and Developmental Biology (GROW), Maastricht University Medical Centre, Maastricht, Limburg, the Netherlands Zelis Maartje Department of Obstetrics and Gynecology, Zuyderland Medical Centre, Heerlen, Limburg, the Netherlands Zwaan Iris M. Department of Obstetrics and Gynecology, Laurentius Hospital, Roermond, Limburg, the Netherlands Spaanderman Marc E. A. Department of Obstetrics and Gynecology, School for Oncology and Developmental Biology (GROW), Maastricht University Medical Centre, Maastricht, Limburg, the Netherlands Scheepers Hubertina C. J. Department of Obstetrics and Gynecology, School for Oncology and Developmental Biology (GROW), Maastricht University Medical Centre, Maastricht, Limburg, the Netherlands Pim van Montfort, Department of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, PO Box 616, 6200 MD, Maastricht, the Netherlands ( [email protected] ). 11 2019 0272989X19889890 14 6 2019 30 10 2019 © The Author(s) 2019 2019 Society for Medical Decision Making This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( http://www.creativecommons.org/licenses/by-nc/4.0/ ) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ( https://us.sagepub.com/en-us/nam/open-access-at-sage ). Background . Despite improved management, preeclampsia remains an important cause of maternal and neonatal mortality and morbidity. Low-dose aspirin (LDA) lowers the risk of preeclampsia. Although several guidelines recommend LDA prophylaxis in women at increased risk, they disagree about the definition of high risk. Recently, an externally validated prediction model for preeclampsia was implemented in a Dutch region combined with risk-based obstetric care paths. Objectives . To demonstrate the selection of a risk threshold and to evaluate the adherence of obstetric health care professionals to the prediction tool. Study Design . Using a survey ( n = 136) and structured meetings among health care professionals, possible cutoff values at which LDA should be discussed were proposed. The prediction model, with chosen cutoff and corresponding risk-based care paths, was embedded in an online tool. Subsequently, a prospective multicenter cohort study ( n = 850) was performed to analyze the adherence of health care professionals. Patient questionnaires, linked to the individual risk profiles calculated by the online tool, were used to evaluate adherence. Results . Health care professionals agreed upon employing a tool with a high detection rate (cutoff: 3.0%; sensitivity 75%, specificity 64%) followed by shared decision between patients and health care professionals on LDA prophylaxis. Of the 850 enrolled women, 364 women had an increased risk of preeclampsia. LDA was discussed with 273 of these women, resulting in an 81% adherence rate. Conclusion . Consensus regarding a suitable risk cutoff threshold was reached. The adherence to this recommendation was 81%, indicating adequate implementation. aspirin adherence implementation prediction preeclampsia pregnancy shared decision making ZonMw https://doi.org/10.13039/501100001826 209020007 ZonMw https://doi.org/10.13039/501100001826 505200098150 edited-state corrected-proof The author(s) received no financial support for the research, authorship, and/or publication of this article. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Financial support for this study was provided entirely by a grant from ZonMw (The Netherlands Organization for Health Research and Development; federal funding). The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report. Study Cohort Registration Netherlands Trial Register NTR4143; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4143 ORCID iDs Pim van Montfort https://orcid.org/0000-0001-7292-9810 Stephanie M. P. Lemmens https://orcid.org/0000-0002-0312-897X Supplemental Material Supplementary material for this article is available on the Medical Decision Making Web site at http://journals.sagepub.com/home/mdm .
Publisher Copyright:
© The Author(s) 2019.
PY - 2020/1
Y1 - 2020/1
N2 - Background. Despite improved management, preeclampsia remains an important cause of maternal and neonatal mortality and morbidity. Low-dose aspirin (LDA) lowers the risk of preeclampsia. Although several guidelines recommend LDA prophylaxis in women at increased risk, they disagree about the definition of high risk. Recently, an externally validated prediction model for preeclampsia was implemented in a Dutch region combined with risk-based obstetric care paths. Objectives. To demonstrate the selection of a risk threshold and to evaluate the adherence of obstetric health care professionals to the prediction tool. Study Design. Using a survey (n = 136) and structured meetings among health care professionals, possible cutoff values at which LDA should be discussed were proposed. The prediction model, with chosen cutoff and corresponding risk-based care paths, was embedded in an online tool. Subsequently, a prospective multicenter cohort study (n = 850) was performed to analyze the adherence of health care professionals. Patient questionnaires, linked to the individual risk profiles calculated by the online tool, were used to evaluate adherence. Results. Health care professionals agreed upon employing a tool with a high detection rate (cutoff: 3.0%; sensitivity 75%, specificity 64%) followed by shared decision between patients and health care professionals on LDA prophylaxis. Of the 850 enrolled women, 364 women had an increased risk of preeclampsia. LDA was discussed with 273 of these women, resulting in an 81% adherence rate. Conclusion. Consensus regarding a suitable risk cutoff threshold was reached. The adherence to this recommendation was 81%, indicating adequate implementation.
AB - Background. Despite improved management, preeclampsia remains an important cause of maternal and neonatal mortality and morbidity. Low-dose aspirin (LDA) lowers the risk of preeclampsia. Although several guidelines recommend LDA prophylaxis in women at increased risk, they disagree about the definition of high risk. Recently, an externally validated prediction model for preeclampsia was implemented in a Dutch region combined with risk-based obstetric care paths. Objectives. To demonstrate the selection of a risk threshold and to evaluate the adherence of obstetric health care professionals to the prediction tool. Study Design. Using a survey (n = 136) and structured meetings among health care professionals, possible cutoff values at which LDA should be discussed were proposed. The prediction model, with chosen cutoff and corresponding risk-based care paths, was embedded in an online tool. Subsequently, a prospective multicenter cohort study (n = 850) was performed to analyze the adherence of health care professionals. Patient questionnaires, linked to the individual risk profiles calculated by the online tool, were used to evaluate adherence. Results. Health care professionals agreed upon employing a tool with a high detection rate (cutoff: 3.0%; sensitivity 75%, specificity 64%) followed by shared decision between patients and health care professionals on LDA prophylaxis. Of the 850 enrolled women, 364 women had an increased risk of preeclampsia. LDA was discussed with 273 of these women, resulting in an 81% adherence rate. Conclusion. Consensus regarding a suitable risk cutoff threshold was reached. The adherence to this recommendation was 81%, indicating adequate implementation.
KW - aspirin
KW - adherence
KW - implementation
KW - prediction
KW - preeclampsia
KW - pregnancy
KW - shared decision making
KW - HIGH-RISK
KW - ASPIRIN
KW - PREGNANCIES
KW - GUIDELINES
KW - MIDWIVES
KW - PLACEBO
U2 - 10.1177/0272989X19889890
DO - 10.1177/0272989X19889890
M3 - Article
C2 - 31789093
SN - 0272-989X
VL - 40
SP - 81
EP - 89
JO - Medical Decision Making
JF - Medical Decision Making
IS - 1
M1 - ARTN 0272989X19889890
ER -